Neurocysticercosis five new things

Neurology: Clinical Practice

Volumn 3, Issue 2, 2013, Pages 118-125

  Carpio, Arturo ^a,b   Fleury, Agnès ^c   Allen Hauser, W ^b  

^a UNIVERSIDAD DE CUENCA   (Ecuador)

^b Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^c INSTITUTO DE INVESTIGACIONES BIOMÉDICAS   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANALGESIC AGENT; CORTICOSTEROID; GELATINASE B; MANNITOL; PRAZIQUANTEL; STEROID;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CENTRAL NERVOUS SYSTEM; CLINICAL PRACTICE; DIZZINESS; ENDOTHELIUM CELL; EPILEPSY; GENETIC DIFFERENCE; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; HEADACHE; HOST; HUMAN; IMMUNE RESPONSE; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; LYMPHOCYTE; NEUROCYSTICERCOSIS; NEUROLOGIC DISEASE; NONHUMAN; PARASITE; PRIORITY JOURNAL; SEIZURE; T LYMPHOCYTE;

EID: 84880099054     PISSN: 21630402     EISSN: 21630933     Source Type: Journal    
DOI: 10.1212/CPJ.0b013e31828d9f17     Document Type: Article

References (20)

1. Carpio A. Neurocysticercosis: an update. Lancet Infect Dis 2002;2:751-762.
2. Fleury A, Escobar A, Fragoso G, Sciutto E, Larralde C. Clinical heterogeneity of human neurocysticercosis results from complex interactions among parasite, host and environmental factors. Trans R Soc Trop Med Hyg 2010;104:243-250.
3. Gupta RK, Awasthi R, Rathore RK, et al. Understanding epileptogenesis in calcified neurocysticercosis with perfusion MRI. Neurology 2012;78:618-625.
4. Verma A, Prasad KN, Gupta RK, et al. Toll-like receptor 4 polymorphism and its association with symptomatic neurocysticercosis. J Infect Dis 2010;202:1219-1225.
5. Bobes RJ, Fragoso G, Reyes-Montes MR, et al. Genetic diversity of Taenia solium cysticerci from naturally infected pigs of central Mexico. Vet Parasitol 2010;26: 130-135.
6. Aguilar-Díaz H, Bobes RJ, Carrero JC, et al. The genome project of Taenia solium. Parasitol Int 2006; 55(suppl):S127-130.
7. Fleury A, Carrillo-Mezo R, Flisser A, Sciutto E, Corona T. Subarachnoid basal neurocysticercosis: a focus on the most severe form of the disease. Expert Rev Anti Infect Ther 2011;9:123-133.
8. Adalid-Peralta L, Fleury A, García-Ibarra TM, et al. Human neurocysticercosis: in vivo expansion of peripheral regulatory T cells and their recruitment in the central nervous system. J Parasitol 2012;98: 142-148.
9. Nash TE, Pretell EJ, Lescano AG, et al. Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case-control study. Lancet Neurol 2008;7: 1099-1105.
10. Agapejev S. Neurocysticercosis: the enigmatic disease. Cent Nerv Syst Agents Med Chem 2011;11: 261-284.
11. Gundra UM, Mishra BB, Wong K, Teale JM. Increased disease severity of parasite-infected TLR2-/- mice is correlated with decreased central nervous system inflammation and reduced numbers of cells with alternatively activated macrophage phenotypes in a murine model of neurocysticercosis. Infect Immun 2011;79:2586-2596.
12. Kelvin EA, Carpio A, Bagiella E, et al. The association of host age and gender with inflammation around neurocysticercosis cysts. Ann Trop Med Parasitol 2009;103:487-499.
13. Beghi E, Carpio A, Forsgren L, et al. Recommendation for a definition of acute symptomatic seizure. Epilepsia 2010;51:671-675.
14. Almeida CR, Ojopi EP, Nunes CM, et al. Taenia solium DNA is present in the cerebrospinal fluid of neurocysticercosis patients and can be used for diagnosis. Eur Arch Psychiatry Clin Neurosci 2006; 256:307-310.
15. Del Brutto OH, Rajshekhar V, White AC Jr, et al. Proposed diagnostic criteria for neurocysticercosis. Neurology 2001;57:177-183.
16. Carpio A, Kelvin E, Bagiella E, et al. The effects of albendazole treatment on neurocysticercosis: a randomized controlled trial. J Neurol Neurosurg Psychiatry 2008;79:1050-1055.
17. Del Brutto OH, Roos KL, Coffey CS, Garcia HH. Meta-analysis: cysticidal drugs for neurocysticercosis: albendazole and praziquantel. Ann Intern Med 2006;45:43-51.
18. Abba K, Ramaratnam S, Ranganathan LN. Anthelmintics for people with neurocysticercosis. Cochrane Database Syst Rev 2010;17:CD000215.
19. Garcia H, Pretell E, Gilman R, et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med 2004;350:249-258.
20. Singh G, Rajshekhar V, Murthy JM, et al. A diagnostic and therapeutic scheme for a solitary cysticercus granuloma. Neurology 2010;75:2236-2245.